Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause

PHASE3CompletedINTERVENTIONAL
Enrollment

650

Participants

Timeline

Start Date

October 31, 2005

Study Completion Date

March 31, 2007

Conditions
Vaginal Atrophy
Interventions
DRUG

Bazedoxifene/Conjugated Estrogen

Trial Locations (63)

30328

Atlanta

33180

Aventura

80202

Denver

91786

Upland

Unknown

Birmingham

Montgomery

Scottsdale

Tucson

Oakland

San Diego

Avon

Groton

Waterbury

Gainesville

Miami

Palm Harbor

Palm Springs

Pinnellas Park

Stuart

Tampa

West Palm Beach

Conyers

Douglasville

Savannah

Idaho Falls

Champaign

Chicago

Kansas City

Shreveport

Baltimore

Ann Arbor

Booklyn Center

Chaska

Jackson

Kansas

Creve Cour

St Louis

Lebanon

Livingston

New Brunswick

Winston-Salem

Fargo

Jamestown

Cincinnati

Columbus

Toledo

Oklahoma City

Medford

Erie

Media

West Reading

Hilton Head Island

Sioux Falls

Nashville

Dallas

Denton

Galveston

San Antonio

Salt Lake City

Burlington

Norfolk

Richmond

Seattle

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00238732 - Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause | Biotech Hunter | Biotech Hunter